Financials
Financial year 2023
Worth noting
- Little cash and receivables against the short-term debts.
- Figures corrected afterwards (2021).
Revenue
€ 8.5 million
▼ 1% vs 2022
Profit
Growing€ 399,596
▲ 38% vs 2022
Debts
Low€ 3.4 million
▲ 6% vs 2022
ARKOPHARMA BELUX from Wavre, company number BE0401962852, closed financial year 2023 with a result of € 399,596 after tax. For that financial year ARKOPHARMA BELUX recorded revenue of € 8.5 million and equity of € 1.9 million. Compared with financial year 2022, the result moved from € 289,452 to € 399,596. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 28, 2025.
What happened at ARKOPHARMA BELUX?
What happened at ARKOPHARMA BELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- PATRICK VERBELEN stepped down as director. NBB
- Dermapharm stepped down as director. NBB
- Olivier Ricq stepped down as director. NBB
- New annual accounts for financial year 2023: profit of € 399,596 (▲ 38% vs 2022). filed late Source: NBB ↗
- PATRICK VERBELEN became a director. NBB
- Dermapharm became a director. NBB
- Olivier Ricq became a director. NBB
- New establishment in Wavre. KBO
In short
From € 267,262 profit in 2021 to € 399,596 profit in 2023.
Paid € 348,923 in corporate taxes since 2021.
Best year ever: 2023, with € 399,596 profit.
Paid out € 250,000 in dividends to the owners in total.
A new publication or filing at ARKOPHARMA BELUX? We notify you, reason included.
Follow ARKOPHARMA BELUXNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2023 annual accounts
PATRICK VERBELEN
Director
since 2023 · until 2026
Dermapharm
Managing director
since 2023 · until 2026
Olivier Ricq
Director
since 2023 · until 2026
Establishments
Establishment units
Physical locations of this company
Avenue Edison 13
1300 Wavre
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0401.962.852
- VAT number
- BE 0401.962.852
- Registered office
- Avenue Edison 13, 1300 Wavre
- Names & denominations
- ARKOPHARMA BELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 1943
- Peppol
- Active · Active since 17 Nov 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Groothandel in chemische producten voor industrieel gebruik
Groothandel in chemische producten